off brand semaglutide Off-brand Ozempic and Wegovy weight-loss drugs are a bad idea, FDA says Wegovy® Lawsuit | July 2026
Description
doi: 10.1016/j.expneurol.2006.09.028
In participants with metabolic dysfunction-associated steatotic liver disease (MASLD), retatrutide demonstrated an 82.4% reduction in liver fat content [4]
However, Wegovy still produces extraordinary results (13.720.7% depending on dose), is cheaper, and has the additional cardiovascular benefit label from the SELECT trial
Some bills have stalled while others remain alive, including a proposal in Arkansas requiring GLP-1s to be covered under Medicaid when prescribed specifically for weight loss
Published in the Lancet Psychiatry, the research also examined data on new diagnoses of anxiety and depression
Nutrient Recommendations: Dietary Reference Intakes (DRI)
